INCLUSIVE
7078
Kufu
4376
Chordia Therapeutics
190A
Cube
7112
Welby
4438
(FY)2024/09/30 | (Q2)2024/03/31 | (Q1)2023/12/31 | (FY)2023/09/30 | (Q4)2023/09/30 | (Q3)2023/06/30 | (Q2)2023/03/31 | (Q1)2022/12/31 | (FY)2022/09/30 | (Q4)2022/09/30 | |
---|---|---|---|---|---|---|---|---|---|---|
營業總收入 | -22.00%18.26億 | -25.02%4.54億 | -21.02%5.06億 | 3.87%23.41億 | -22.88%5.15億 | -8.24%5.8億 | 24.09%6.05億 | 37.54%6.4億 | -6.29%22.54億 | 12.18%6.68億 |
主營業務成本 | -19.84%8.89億 | -16.76%2.22億 | -24.35%2.38億 | 15.51%11.09億 | -28.55%2.53億 | -15.30%2.74億 | 79.26%2.67億 | 136.64%3.15億 | 3.68%9.6億 | 53.55%3.55億 |
毛利 | -23.95%9.37億 | -31.53%2.32億 | -17.81%2.68億 | -4.76%12.32億 | -16.47%2.62億 | -0.84%3.06億 | -0.14%3.38億 | -2.09%3.26億 | -12.53%12.94億 | -14.03%3.13億 |
營業費用 | -24.51%9.94億 | -20.35%2.53億 | -27.13%2.77億 | -11.65%13.16億 | -25.94%3.05億 | -32.53%3.12億 | -0.84%3.18億 | 29.51%3.81億 | 45.90%14.9億 | 49.61%4.12億 |
營業利潤 | 32.73%-5,632.2萬 | -203.94%-2,142.6萬 | 82.32%-971.6萬 | 57.20%-8,373萬 | 55.95%-4,360.4萬 | 96.24%-578.2萬 | 12.11%2,061.3萬 | -242.06%-5,495.7萬 | -142.69%-1.96億 | -211.30%-9,899.1萬 |
營業外利息收入與支出淨額 | -58.50%-428.1萬 | -139.60%-107.1萬 | -69.29%-86萬 | -74.94%-270.1萬 | -154.84%-118.5萬 | -17.12%-56.1萬 | -56.29%-44.7萬 | -61.78%-50.8萬 | -2.18%-154.4萬 | -38.39%-46.5萬 |
營業外利息收入 | 944.44%9.4萬 | ---- | ---- | -25.00%9,000 | ---- | ---- | ---- | ---- | 0.00%1.2萬 | ---- |
營業外利息支出 | 61.44%437.5萬 | 139.60%107.1萬 | 69.29%86萬 | 74.16%271萬 | 150.31%119.4萬 | 17.12%56.1萬 | 56.29%44.7萬 | 61.78%50.8萬 | 2.17%155.6萬 | 39.47%47.7萬 |
投資淨收益 | 49.56%33.8萬 | 0 | 49.78%33.7萬 | 100.00%22.6萬 | 1,000 | 0 | 0 | 100.89%22.5萬 | 11.3萬 | 0 |
被指定為現金流套期的金融工具損益 | ||||||||||
終止確認可供出售金融資產損益 | 70.00%-1,499.9萬 | -1,997.27%-4,999.9萬 | 66.96%-238.4萬 | |||||||
聯營企業及其他參股權益產生的收益 | ||||||||||
特殊收入(費用) | -90,352.90%-2.34億 | 10.8萬 | 431.4萬 | 25.9萬 | 0 | 0 | ||||
減:其他特殊費用 | -2,731.66%-733.4萬 | ---10.8萬 | ---431.4萬 | ---25.9萬 | ---- | ---- | ---- | ---- | ---- | ---- |
減:勾銷 | --2.41億 | ---- | ---- | --0 | ---- | ---- | ---- | ---- | ---- | ---- |
其他營業外收入(費用) | -80.84%180.4萬 | -95.30%18.5萬 | -82.81%28.7萬 | 251.27%941.4萬 | -97.17%21.6萬 | 42.43%359.2萬 | 160.01%393.6萬 | 281.52%167萬 | 140.57%268萬 | 152,640.00%763.7萬 |
稅前利潤 | -142.80%-3.07億 | -192.12%-2,220.3萬 | 89.48%-563.7萬 | 35.70%-1.27億 | -0.12%-9,431.2萬 | 98.19%-275.1萬 | 108.79%2,410.3萬 | -242.61%-5,356.9萬 | -145.23%-1.97億 | -229.26%-9,420.3萬 |
所得稅 | 5,949.37%8,626.4萬 | -123.38%-252.7萬 | 107.12%91.6萬 | 106.77%142.6萬 | 98.02%-42.2萬 | 111.65%390.7萬 | -11.82%1,080.7萬 | -159.63%-1,286.6萬 | -114.55%-2,106萬 | -280.92%-2,136.7萬 |
除稅後利潤 | -207.51%-3.93億 | -247.98%-1,967.5萬 | 83.90%-655.3萬 | 27.18%-1.28億 | -28.91%-9,389萬 | 94.36%-665.9萬 | 1,970.04%1,329.6萬 | -354.60%-4,070.3萬 | -160.53%-1.76億 | -219.26%-7,283.5萬 |
持續經營利潤 | -207.51%-3.93億 | -247.98%-1,967.6萬 | 83.90%-655.3萬 | 27.18%-1.28億 | -28.91%-9,389萬 | 94.37%-665.8萬 | 1,970.04%1,329.6萬 | -354.60%-4,070.3萬 | -160.53%-1.76億 | -219.27%-7,283.6萬 |
歸屬于少數股東的淨利潤 | 6.5萬 | 0 | ||||||||
歸屬於母公司的淨利潤 | -207.56%-3.94億 | -247.98%-1,967.5萬 | 83.90%-655.3萬 | 27.18%-1.28億 | -28.91%-9,389萬 | 94.36%-665.9萬 | 1,970.04%1,329.6萬 | -354.60%-4,070.3萬 | -160.53%-1.76億 | -219.26%-7,283.5萬 |
優先股派息 | ||||||||||
其他優先股派息 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
歸屬于普通股股東的淨利潤 | -207.56%-3.94億 | -247.98%-1,967.5萬 | 83.90%-655.3萬 | 27.18%-1.28億 | -28.91%-9,389萬 | 94.36%-665.9萬 | 1,970.04%1,329.6萬 | -354.60%-4,070.3萬 | -160.53%-1.76億 | -219.26%-7,283.5萬 |
總派息金額 | ||||||||||
基本每股收益 | -207.00%-36.84 | -248.00%-1.85 | 84.03%-0.61 | 27.27%-12 | -28.65%-8.8 | 94.32%-0.63 | 1,885.71%1.25 | -354.67%-3.82 | -160.28%-16.5 | -219.37%-6.84 |
稀釋每股收益 | -207.00%-36.84 | -248.33%-1.85 | 84.03%-0.61 | 27.27%-12 | -28.65%-8.8 | 94.32%-0.63 | 1,881.78%1.2472 | -356.38%-3.82 | -160.82%-16.5 | -219.79%-6.84 |
每股派息 | ||||||||||
貨幣單位 | 日元 | 日元 | 日元 | 日元 | 日元 | 日元 | 日元 | 日元 | 日元 | 日元 |
會計準則 | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |